Serum fucosylation changes in oral cancer and oral precancerous conditions: α-L-fucosidase as a marker

Cancer

Volumn 113, Issue 2, 2008, Pages 336-346

  Shah, Manisha ^a   Telang, Shaila ^b   Raval, Gira ^a   Shah, Pankaj ^a   Patel, Prabhudas S ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

L fucosidase; Fucose; Fucosylated glycoproteins; Fucosylation; Fucosyltransferase; Oral cancer; Oral precancerous conditions

Indexed keywords

ALPHA LEVO FUCOSIDASE; FUCOSE; FUCOSYLTRANSFERASE; LECTIN;

ADOLESCENT; ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME ACTIVITY; FEMALE; FOLLOW UP; FUCOSYLATION; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; PATIENT MONITORING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-L-FUCOSIDASE; ANTINEOPLASTIC AGENTS; FEMALE; FUCOSE; HEALTH; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 48249114327     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23556     Document Type: Article

References (40)

1. Alhadeff JA. Malignant cell glycoproteins and glycolipids. Crit Rev Oncol Hematol. 1989;9:37-107.
2. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 1989;52: 257-331.
3. Orczyk-Pawilowicz M. [The role of fucosylation of glycoconjugates in health and disease]. Postepy Hig Med Dosw [serial online]. 2007;61:240-252.
4. MacDougall SL, Schwarting GA, Parkinson D, Sullivan AK. Increased fucosylation of glycolipids in a human leukaemia cell line (K562-Clone I) with decreased sensitivity to NK-mediated lysis. Immunology. 1987;62:75-80.
5. Youakim A, Herscovics A. Cell surface glycopeptides from human intestinal epithelial cell lines derived from normal colon and colon adenocarcinomas. Cancer Res. 1985;45(11 pt 1):5505-5511.
6. Fernandez-Rodriguez J, Paez de la Cadena M, Martinez-Zorzano VS, Rodriguez-Berrocal FJ. Fucose levels in sera and in tumours of colorectal adenocarcinoma patients. Cancer Lett. 1997;121:147-153.
7. Rao VR, Krishnamoorthy L, Kumaraswamy SV, Ramaswamy G. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity. Cancer Detect Prev. 1998;22: 237-240.
8. Wang JW, Ambros RA, Weber PB, Rosano TG. Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue. Cancer Res. 1995;55:3654-3658.
9. Patel PS, Baxi BR, Adhvaryu SG, Balar DB. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 1990;10:1071-1074.
10. Patel PS, Adhvaryu SG, Balar DB, Parikh BJ, Shah PM. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. Anticancer Res. 1994;14:747-751.
11. Mita Y, Aoyagi Y, Suda T, Asakura H. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein. J Hepatol. 2000;32:946-954.
12. Hutchinson WL, Du MQ, Johnson PJ, Williams R. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology. 1991; 13:683-688.
13. Takahashi T, Ikeda Y, Miyoshi E, Yaginuma Y, Ishikawa M, Taniguchi N. Alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer. 2000;88:914-919.
14. Rudiger H, Gabius HJ. Plant lectins: occurrence, biochemistry, functions and applications. Glycoconj J. 2001;18:589-613.
15. Thompson S, Turner GA. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer. 1987;56:605-610.
16. Thompson S, Cantwell BM, Cornell C, Turner GA. Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis. Br J Cancer. 1991;64: 386-390.
17. Kossowska B, Ferens-Sieczkowska M, Gancarz R, Passowicz-Muszynska E, Jankowska R. Fucosylation of serum glycoproteins in lung cancer patients. Clin Chem Lab Med. 2005;43:361-369.
18. Noda K, Miyoshi E, Kitada T, et al. The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase. Tumour Biol. 2002;23:202-211.
19. Listinsky JJ, Siegal GP, Listinsky CM. Alpha-L-fucose: a potentially critical molecule in pathologic processes including neoplasia. Am J Clin Pathol. 1998;110:425-440.
20. Togayachi A, Kudo T, Ikehara Y, et al. Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type alpha1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer. Int J Cancer. 1999;83:70-79.
21. Ayude D, Fernandez-Rodriguez J, Rodriguez-Berrocal FJ, et al. Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer. Oncology. 2000;59:310-316.
22. Abdel-Aleem H, Ahmed A, Sabra AM, Zakhari M, Soliman M, Hamed H. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors. Int J Gynaecol Obstet. 1996;55:273-279.
23. Fernandez-Rodriguez J, Ayude D, de la Cadena MP, et al. Alpha-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence. Cancer Detect Prev. 2000;24:143-149.
24. Ayude D, Paez de la Cadena M, Martinez-Zorzano VS, Fernandez-Briera A, Rodriguez-Berrocal FJ. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer. Oncology. 2003;64:36-45.
25. Giardina MG, Matarazzo M, Morante R, et al. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis. Cancer. 1998;83:2468-2474.
26. Indian Council of Medical Research. ICMR Bulletin. National Cancer Registry of the Indian Council for Medical Research Annual Report, January 2001. New Delhi, India: ICMR; 2001.
27. Oliver RJ, MacDonald DG, Felix DH. Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med. 2000;29:49-55.
28. International Union Against Cancer. Head and neck tumors. In: Spiessl B, Hermanek E, Scheibe O, et al, eds. TNM Atlas, Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. 3rd ed. Heidelberg, Germany: Springer-Verlag; 1990:3-61.
29. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-216.
30. Winzler RJ. Determination of serum glycoproteins. Methods Biochem Anal. 1955;2:279-311.
31. Yazawa S, Madiyalakan R, Izawa H, Asao T, Furukawa K, Matta KL. Cancer-associated elevation of alpha(1-3)-L-fucosyltransferase activity in human serum. Cancer. 1988; 62:516-520.
32. Wiederschain GY, Rosenfeld EL, Brusilovsky AI, Kolibaba LG. α-L-fucosidase and other glycosidases in human placenta, foetus liver and amniotic fluid at various stages of gestation. Clin Chim Acta. 1971;35:99-107.
33. Shashikanth MC, Rao BB. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinoma. Indian J Dent Res. 1994;5:119-124.
34. Montreuil J, Vliegenthart JFG, Schachter H, eds. Glycoproteins II (New Comprehensive Biochemistry). Amsterdam, the Netherlands: Elsevier; 1997.
35. Shirahama T, Ikoma M, Muramatsu T, et al. The binding site for fucose-binding proteins of Lotus tetragonolobus is a prognostic marker for transitional cell carcinoma of the human urinary bladder. Cancer. 1993;72:1329-1334.
36. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J. 1997; 14:577-584.
37. Wallack MK, Brown AS, Rosato EF, Rubin S, Johnson JL, Rosato FE. Serum fucose as a monitor for recurrent malignancy. J Surg Oncol. 1978;10:39-44.
38. Bauer CH, Reutter WG, Erhart KP, Kottgen E, Gerok W. Decrease of human serum fucosyltransferase as an indicator of successful tumor therapy. Science. 1978;201:1232-1233.
39. Yazawa S, Asao T, Nagamachi Y, Abbas SA, Matta KL. Tumor-related elevation of serum (alpha 1-3)-L-fucosyltransferase activity in gastric cancer. J Cancer Res Clin Oncol. 1989;115:451-455.
40. Takahashi H, Saibara T, Iwamura S, et al. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma. Hepatology. 1994;19:1414-1417.